NO924679L - Kontrastmidler for ultralydbilleder - Google Patents

Kontrastmidler for ultralydbilleder

Info

Publication number
NO924679L
NO924679L NO92924679A NO924679A NO924679L NO 924679 L NO924679 L NO 924679L NO 92924679 A NO92924679 A NO 92924679A NO 924679 A NO924679 A NO 924679A NO 924679 L NO924679 L NO 924679L
Authority
NO
Norway
Prior art keywords
contractors
ultra sound
sound images
contrast agents
dispersed microbubbles
Prior art date
Application number
NO92924679A
Other languages
English (en)
Norwegian (no)
Other versions
NO924679D0 (no
Inventor
Joseph Yudelson
Susan E Power
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of NO924679D0 publication Critical patent/NO924679D0/no
Publication of NO924679L publication Critical patent/NO924679L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/225—Microparticles, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
NO92924679A 1991-12-04 1992-12-04 Kontrastmidler for ultralydbilleder NO924679L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/803,293 US5196183A (en) 1991-12-04 1991-12-04 Contrast agents for ultrasound imaging

Publications (2)

Publication Number Publication Date
NO924679D0 NO924679D0 (no) 1992-12-04
NO924679L true NO924679L (no) 1993-06-07

Family

ID=25186146

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924679A NO924679L (no) 1991-12-04 1992-12-04 Kontrastmidler for ultralydbilleder

Country Status (22)

Country Link
US (1) US5196183A (ko)
EP (1) EP0547654A1 (ko)
JP (1) JP2769077B2 (ko)
KR (1) KR930012039A (ko)
CN (1) CN1073880A (ko)
AU (1) AU2857292A (ko)
BR (1) BR9204841A (ko)
CA (1) CA2084432A1 (ko)
CZ (1) CZ352992A3 (ko)
FI (1) FI925526A (ko)
HU (2) HU9203845D0 (ko)
IL (1) IL103951A0 (ko)
IS (1) IS3955A (ko)
MX (1) MX9206980A (ko)
MY (1) MY134715A (ko)
NO (1) NO924679L (ko)
PL (1) PL296827A1 (ko)
SK (1) SK352992A3 (ko)
TN (1) TNSN92111A1 (ko)
TW (1) TW221791B (ko)
UY (1) UY23515A1 (ko)
YU (1) YU103792A (ko)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US6001335A (en) 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5305757A (en) 1989-12-22 1994-04-26 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US6146657A (en) 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US5352435A (en) * 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
US20020150539A1 (en) * 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5776429A (en) 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5656211A (en) * 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5874062A (en) * 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US5993805A (en) 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
AU5321694A (en) * 1992-10-06 1994-04-26 Molecular Biosystems, Inc. Method of ultrasonic imaging of body cavities
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
JP3559849B2 (ja) * 1993-07-30 2004-09-02 アイエムシーオーアール ファーマシューティカル カンパニー 超音波技術のための安定化された微小気泡組成物
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US5736121A (en) * 1994-05-23 1998-04-07 Imarx Pharmaceutical Corp. Stabilized homogenous suspensions as computed tomography contrast agents
US5509896A (en) * 1994-09-09 1996-04-23 Coraje, Inc. Enhancement of thrombolysis with external ultrasound
US5540909A (en) * 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US6743779B1 (en) 1994-11-29 2004-06-01 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US6033645A (en) 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
JP2001507207A (ja) 1996-05-01 2001-06-05 イマアーレクス・フアーマシユーチカル・コーポレーシヨン 化合物を細胞に送達する方法
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
US6017310A (en) * 1996-09-07 2000-01-25 Andaris Limited Use of hollow microcapsules
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
ES2289188T3 (es) 1996-09-11 2008-02-01 Bristol-Myers Squibb Medical Imaging, Inc. Procedimiento para la obtencion de imagenes para el diagnostico usando un agente de contraste y un vasodilatador.
US20070092563A1 (en) 1996-10-01 2007-04-26 Abraxis Bioscience, Inc. Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6143276A (en) 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6537246B1 (en) * 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US20050019266A1 (en) * 1997-05-06 2005-01-27 Unger Evan C. Novel targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6123923A (en) 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US6638230B2 (en) * 2001-07-31 2003-10-28 Koninklijke Philips Electronics N.V. Apparatus and method of frequency compounding to perform contrast imaging
US7737097B2 (en) * 2003-06-27 2010-06-15 Lam Research Corporation Method for removing contamination from a substrate and for making a cleaning solution
US8364256B2 (en) * 2004-11-15 2013-01-29 Coraje, Inc. Method and apparatus of removal of intravascular blockages
CN100574809C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
CN100574811C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用微粒类助剂及其应用
ES2407982T3 (es) * 2006-09-13 2013-06-17 Holtec International, Inc. Aparato y método para soportar conjuntos combustibles en un entorno subacuático que tiene carga de acceso lateral
US9757462B2 (en) 2010-11-19 2017-09-12 Sapporo Medical University Combined pharmaceutical preparation
ES2821966T3 (es) 2014-04-02 2021-04-28 Nitto Denko Corp Molécula de direccionamiento derivada de RBP y utilización de la misma
GB201415681D0 (en) * 2014-09-04 2014-10-22 Cambridge Entpr Ltd And President And Fellows Of Harvard College Protien Capsules
WO2022014762A1 (ko) * 2020-07-16 2022-01-20 ㈜에어레인 연소배가스의 이산화탄소 포집 및 질소 농축을 동시에 수행하는 다단 막분리공정

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4718433A (en) * 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
US4572203A (en) * 1983-01-27 1986-02-25 Feinstein Steven B Contact agents for ultrasonic imaging
DE3834705A1 (de) * 1988-10-07 1990-04-12 Schering Ag Ultraschallkontrastmittel aus gasblaeschen und fettsaeure enthaltenden mikropartikeln
PT81498B (pt) * 1984-11-23 1987-12-30 Schering Ag Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas
DE3529195A1 (de) * 1985-08-14 1987-02-26 Max Planck Gesellschaft Kontrastmittel fuer ultraschalluntersuchungen und verfahren zu seiner herstellung
US4844882A (en) * 1987-12-29 1989-07-04 Molecular Biosystems, Inc. Concentrated stabilized microbubble-type ultrasonic imaging agent
US4957656A (en) * 1988-09-14 1990-09-18 Molecular Biosystems, Inc. Continuous sonication method for preparing protein encapsulated microbubbles

Also Published As

Publication number Publication date
BR9204841A (pt) 1993-06-08
FI925526A (fi) 1993-06-05
TNSN92111A1 (fr) 1993-06-08
JPH05194278A (ja) 1993-08-03
HU9203845D0 (en) 1993-03-29
CA2084432A1 (en) 1993-06-05
AU2857292A (en) 1993-06-17
FI925526A0 (fi) 1992-12-04
IS3955A (is) 1993-06-05
HUT67164A (en) 1995-02-28
CN1073880A (zh) 1993-07-07
MX9206980A (es) 1993-06-01
YU103792A (sh) 1995-12-04
NO924679D0 (no) 1992-12-04
MY134715A (en) 2007-12-31
UY23515A1 (es) 1993-05-21
US5196183A (en) 1993-03-23
SK352992A3 (en) 1994-12-07
IL103951A0 (en) 1993-05-13
EP0547654A1 (en) 1993-06-23
JP2769077B2 (ja) 1998-06-25
CZ352992A3 (en) 1993-09-15
PL296827A1 (en) 1993-12-27
TW221791B (ko) 1994-03-21
KR930012039A (ko) 1993-07-20

Similar Documents

Publication Publication Date Title
NO924679L (no) Kontrastmidler for ultralydbilleder
NO306198B1 (no) Kovalent modifiserte mikropartikulaere kontrastmidler
BR9906530A (pt) Compósito odontológico
IL116328A (en) Frozen suspension of gas microbubbles in frozen aqueous carrier for use as contrast agent in ultrasonic imaging
DE69002767T2 (de) Fluor- und phosphorhaltige amphiphilische moleküle mit oberflächenaktiven eigenschaften.
DE60026544D1 (de) Verwendung von einfachen aminosäuren zur herstellung von porösen partikeln
NO854765L (no) Anvendelse av ferromagnetiske partikler i kontrastmidler for nmr-avbildning og kontrastmidler.
Buchanan et al. Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature
NO942562L (no) Mikropartikulære kontrastmidler
Thakkar et al. An in vitro comparison of casein phosphopeptide-amorphous calcium phosphate paste, casein phosphopeptide-amorphous calcium phosphate paste with fluoride and casein phosphopeptide-amorphous calcium phosphate varnish on the inhibition of demineralization and promotion of remineralization of enamel
NO924481L (no) Innkapslede partikler egnet som kontrastmidler i ultralyd- og roentgenavbildningssammensetninger og -fremgangsmaater
JP2001520207A5 (ko)
NO305012B1 (no) Dispersjoner av magneto-ioniske partikler og anvendelse derav
Osborne et al. Mechanical properties and clinical performance of a gallium restorative material
EA199800881A1 (ru) Способ т1 - взвешенной магниторезонансной визуализации органов ретикуло-эндотелиальной системы
Kshirsagar et al. Comparative assessment of bond strengths of affected dentin, using two different remineralizing solutions with or without lasers: Results of an: in vitro: pilot study
DE69518319T2 (de) Verwendung von oberflächenaktiven substanzen zur stabilisierung von peptiden und proteinen zur radiopharmazeutischen verwendung
Pope Qualifying intensity measurements for sound power determination.
RU92004556A (ru) Контрастное вещество для ультразвуковой диагностики и способ его получения
Tochio et al. Makeup inhibits reduction of reactive oxygen scavenging enzyme activity induced by mental stress
Chakrabarti et al. The effect of plasma fibrinogen levels on measures of fibrinolytic activity
MAREN BLOOD FLOW TO ADIPOSE TISSUES IN THE MALE SPRAGUE-DAWLEY RAT.
FR2846237B1 (fr) Composition sous forme d'emulsion huile-dans-eau et ses utilisations notamment cosmetiques
SEKIGUCHI HUMAN FACTORS IN SPACE
Damato De-and re-mineralisation of human dental enamel using single sections